Presentation TCT 2019 TCT 27: Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: The Disrupt CAD II study Presenter: Ziad Ali September 25, 2019
Presentation TCT 2019 TCT 28: Comparative Study of Resource Utilisation, Costs and Procedural Times of Percutaneous Coronary Intervention with Rotational Atherectomy vs Intravascular Lithotripsy Presenter: Shafeer Rashid September 25, 2019
Presentation TCT 2019 TCT 26: Predictors of Bailout Rotational Atherectomy in Patients With Complex Calcified Coronary Artery Disease: A Pooled Analysis From the Randomized ROTAXUS and PREPARE-CALC Trials Presenter: Mohamed Abdel-Wahab September 25, 2019
Presentation TCT 2019 TCT 25: Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Presenter: Devika Aggarwal September 25, 2019
News Conference News ESC 2019 COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter Yael L. Maxwell September 01, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019
News Daily News Substantial Increase in PCI Survival Over 10 Years: Single Center Yael L. Maxwell August 16, 2019
News Daily News Stroke After PCI: Rare but Rising as Patient Complexity Climbs Todd Neale August 05, 2019
News Daily News FDA Grants Cardiac MR Indication for Gadavist Contrast Injection Shelley Wood July 16, 2019
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019
News Conference News EAS 2019 Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION Michael O'Riordan June 04, 2019
News Conference News EAS 2019 Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients Michael O'Riordan May 30, 2019
News Conference News EAS 2019 CHD Mortality Significantly Elevated in Patients With Severe FH Michael O'Riordan May 29, 2019
News Conference News EuroPCR 2019 New Clarity on Patients at High Risk for Bleeding After PCI Michael O'Riordan May 28, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
Presentation SIF 2019 Performing Zero (Or Low Volume) Contrast PCI in Patients with Advanced Chronic Kidney Disease Presenter: Sripal Bangalore March 28, 2019
News Daily News Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth Todd Neale March 05, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News Breast Calcifications May Hold Important Clues for CV Risk Stratification L.A. McKeown February 22, 2019